Balaji Medware Private Limited
About Balaji Medware Private Limited
Data last updated:
Balaji Medware Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC314019. Its GSTIN is 07AAHCB1125D1ZA (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Munna Kumar Singh and Pawan Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 350 Ground Floor Village Masjid Moth, Near Lila Ram Market, New Delhi, Delhi, India – 110049.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.91 Lakh, a growth of 60% compared to the previous year. For the same year it recorded a net profit of ₹4.44 Lakh (net margin 26.3%) and EBITDA of ₹7.52 Lakh (EBITDA margin 44.5%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address350 Ground Floor Village Masjid Moth, Near Lila Ram Market, New Delhi, Delhi, India – 110049
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Balaji Medware Private Limited
The main business activity of Balaji Medware is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Balaji Medware Private Limited FY 2025 filings available
Balaji Medware Private Limited reported revenue of ₹16.91 Lakh (up 60% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Balaji Medware Private Limited
Revenue rose 60% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 10%. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Balaji Medware Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.52 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.44 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Balaji Medware Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 44.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 26.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Balaji Medware are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Balaji Medware Private Limited
Balaji Medware has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munna Kumar Singh | Director | 11 Aug 2023 | 3 Years 2 Months | Current |
| Pawan Sharma | Director | 10 Apr 2023 | 3 Years 6 Months | Current |
Peer Comparison of Balaji Medware Private Limited
Balaji Medware Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dencia Healthcare Private Limited | ₹17.01 Lakh (FY 2019) | •••• | •••• | -28.0% | •••• | Indore, Madhya Pradesh, India |
| Miopass Pharmaceuticals Private Limited | ₹16.99 Lakh (FY 2024) | •••• | •••• | 27.0% | •••• | Lucknow, Uttar Pradesh, India |
| Unisars Health Care Private Limited | ₹16.98 Lakh (FY 2025) | •••• | •••• | -87.0% | •••• | Agra, Uttar Pradesh, India |
| Isonic Pharmaceuticals Private Limited | ₹16.97 Lakh (FY 2024) | •••• | •••• | 16.0% | •••• | Saketri, Haryana, India |
| Signature Pharmaceuticals Limited | ₹16.97 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Balaji Medware Private Limited this company | ₹16.91 Lakh (FY 2025) | •••• | •••• | 60.0% | •••• | New Delhi, Delhi, India |
| A B R Drugs Private Limited | ₹16.75 Lakh (FY 2024) | •••• | •••• | 9.0% | •••• | New Delhi, Delhi, India |
| Emars Perk Allen Private Limited | ₹16.71 Lakh (FY 2024) | •••• | •••• | -82.0% | •••• | Kolkata, West Bengal, India |
| Ekasar Lifesciences Private Limited | ₹16.68 Lakh (FY 2023) | •••• | •••• | -38.0% | •••• | Chandigarh, India |
| Ritz Pharmaceutical and Foods Products Private Limited | ₹16.68 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | Uttar Prdesh, Uttar Pradesh, India |
| Virgo Welltrade Private Limited | ₹16.66 Lakh (FY 2024) | •••• | •••• | -37.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Balaji Medware by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Balaji Medware Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Balaji Medware Private Limited
Balaji Medware Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Balaji Medware Private Limited
Employment history and EPFO contributions of people linked to Balaji Medware.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Balaji Medware Private Limited
Balaji Medware Private Limited has 8 board changes on record since 2021: 2 appointments and 6 cessations. The latest: Roshni Singh ceased to be Director on 21 Aug 2023.
Credit Ratings, Litigation & Regulatory Alerts for Balaji Medware Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Balaji Medware Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Balaji Medware Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Balaji Medware Private Limited
Balaji Medware has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCB1125D1ZA | Delhi | Active | 12 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Balaji Medware Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Balaji Medware Private Limited
Balaji Medware is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 March 2017 (9+ years old) and is registered under CIN U51909DL2017PTC314019.
Balaji Medware reported revenue of ₹16.91 Lakh for FY 2025 (up 60% YoY).
Balaji Medware has 2 current directors:
- Munna Kumar Singh - Director
- Pawan Sharma - Director
Balaji Medware reported a net profit of ₹4.44 Lakh (net margin 26.3%) and EBITDA of ₹7.52 Lakh (EBITDA margin 44.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Balaji Medware is -16% over three years and -10% over five years. In the latest year (FY 2025) revenue rose 60%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Balaji Medware is 07AAHCB1125D1ZA, registered in Delhi.
The CIN (Corporate Identification Number) of Balaji Medware is U51909DL2017PTC314019. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Balaji Medware was incorporated on 06 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Balaji Medware by revenue are Dencia Healthcare Private Limited, Miopass Pharmaceuticals Private Limited, Unisars Health Care Private Limited, Isonic Pharmaceuticals Private Limited, Signature Pharmaceuticals Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Roshni Singh ceased to be Director on 21 Aug 2023. Munna Kumar Singh was appointed as Director on 11 Aug 2023. Sandeep ceased to be Director on 18 Apr 2023. Balaji Medware has 8 board changes on record in total.
The registered office of Balaji Medware is at 350 Ground Floor Village Masjid Moth, Near Lila Ram Market, New Delhi, Delhi, India – 110049.